{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:48:06Z","timestamp":1783615686686,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University of Toronto, Toronto, Canada"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jogc.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T11:26:23Z","timestamp":1533900383000},"page":"1066-1076.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review"],"prefix":"10.1016","volume":"40","author":[{"given":"Cassandra","family":"De Gasperis-Brigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhbir S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vilos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Kives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally","family":"Murji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jogc.2018.05.020_bib0010","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2018.05.020_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.12.206","article-title":"The past, present and future of selective progesterone receptor modulators in the management of uterine fibroids [e-pub ahead of print]","author":"Singh","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.020_bib0020","author":"European Medicines Agency"},{"key":"10.1016\/j.jogc.2018.05.020_bib0025","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jmig.2015.08.098","article-title":"The role of ethnicity in the treatment of uterine fibroids with ulipristal acetate","volume":"22","author":"Murji","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2018.05.020_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jogc.2018.05.020_bib0035","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2018.05.020_bib0040","author":"National Institute of Health"},{"key":"10.1016\/j.jogc.2018.05.020_bib0045","author":"European Medicines Agency"},{"key":"10.1016\/j.jogc.2018.05.020_bib0050","first-page":"75","article-title":"Ulipristal acetate versus GnRH agonists in the treatment of uterine fibroids","volume":"122","author":"Ene","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2018.05.020_bib0055","first-page":"S136","article-title":"Esmya-the Belfast Trust's experience","volume":"1","author":"Niblock","year":"2015","journal-title":"Gynecol Surg"},{"key":"10.1016\/j.jogc.2018.05.020_bib0060","first-page":"496","article-title":"Pre-treatment with ulipristal acetate before ICSI procedure: a case report","volume":"17","author":"Wdowiak","year":"2013","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.jogc.2018.05.020_bib0065","article-title":"Successful pregnancy after treatment with ulipristal acetate for uterine fibroids","volume":"2014","author":"Monleon","year":"2014","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.020_bib0070","first-page":"32","article-title":"Case report: successful pregnancy after combined preoperative pretreatment with ulipristal acetate and laparoscopic myoma enucleation in deep-seated cervical posterior wall myoma and desire to have children","volume":"25","author":"Romer","year":"2015","journal-title":"J Gynakologische Endokrinologie"},{"key":"10.1016\/j.jogc.2018.05.020_bib0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.17116\/repro201521486-88","article-title":"Successful pregnancy after gigantic uterine fibroids treatment with the help of ulipristal acetate","volume":"21","author":"Tikhomirov","year":"2015","journal-title":"Problemy Reproduktsii"},{"key":"10.1016\/j.jogc.2018.05.020_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jogc.2015.11.004","article-title":"Spontaneous pregnancy following ulipristal acetate treatment in a woman with a symptomatic uterine fibroid","volume":"38","author":"Murad","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.05.020_bib0085","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajog.2016.02.049","article-title":"Long-term nonsurgical control with ulipristal acetate of multiple uterine fibroids, enabling pregnancy","volume":"214","author":"Luyckx","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.020_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.07.1253","article-title":"First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids","volume":"102","author":"Luyckx","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2018.05.020_bib0095","first-page":"150","article-title":"Commentary on the article \u201cpre-treatment with ulipristal acetate before ICSI procedure: a case report\u201d published in Menopause Review 6\/2013 (przeglad menopauzalny 2013; 6: 496\u2013500)","volume":"18","author":"Wdowiak","year":"2014","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.jogc.2018.05.020_bib0100","first-page":"101","article-title":"Successful pregnancy following the complex treatment of gigantic uterine fibroids using ulipristal acetate. Abstract P41. International Society of Gynecologuical Endocrinology, 17th World Congress; 2016 March 2\u20135; Firenze","volume":"32","author":"Tikhomirov","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogc.2018.05.020_bib0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2018.05.020_bib0110","author":"Allergan Pharma Co"},{"key":"10.1016\/j.jogc.2018.05.020_bib0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogc.2018.05.020_bib0120","first-page":"1439","article-title":"Myoma migration: an unexpected \u201ceffect\u201d with ulipristal acetate treatment","volume":"20","author":"Willame","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jogc.2018.05.020_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173523","article-title":"Safety after extended repeated use of ulipristal acetate for uterine fibroids","volume":"12","author":"Fauser","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jogc.2018.05.020_bib0130","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2018.05.020_bib0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ajog.2007.12.039","article-title":"Fibroids and reproductive outcomes: a systematic literature review from conception to delivery","volume":"198","author":"Klatsky","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.020_bib0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/14767058.2014.921675","article-title":"Number and size of uterine fibroids and obstetric outcomes","volume":"28","author":"Ciavattini","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2018.05.020_bib0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos","year":"2015","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318304560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318304560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T01:06:37Z","timestamp":1735088797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216318304560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1701216318304560"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2018.05.020","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}